Bharat Biotech ramps up Covaxin production capacity to 70 crore doses per annum
New Delhi: To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said Tuesday. Manufacturing scale up has been carried out in a...











































